Amphastar Pharmaceuticals Inc (AMPH)
48.02
+0.14
(+0.29%)
USD |
NASDAQ |
Sep 27, 16:00
47.98
-0.04
(-0.08%)
After-Hours: 20:00
Amphastar Pharmaceuticals Cash from Investing (Quarterly): -69.90M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -69.90M |
| March 31, 2024 | 15.24M |
| December 31, 2023 | -103.05M |
| September 30, 2023 | -31.15M |
| June 30, 2023 | -508.58M |
| March 31, 2023 | -6.333M |
| December 31, 2022 | -0.229M |
| September 30, 2022 | -15.26M |
| June 30, 2022 | -8.18M |
| March 31, 2022 | -9.11M |
| December 31, 2021 | -11.95M |
| September 30, 2021 | -3.769M |
| June 30, 2021 | -4.254M |
| March 31, 2021 | -8.695M |
| December 31, 2020 | -12.18M |
| September 30, 2020 | -5.451M |
| June 30, 2020 | -10.07M |
| March 31, 2020 | -8.722M |
| December 31, 2019 | -7.352M |
| September 30, 2019 | -18.62M |
| June 30, 2019 | -9.669M |
| March 31, 2019 | -14.88M |
| December 31, 2018 | -8.797M |
| Date | Value |
|---|---|
| September 30, 2018 | -12.88M |
| June 30, 2018 | -11.77M |
| March 31, 2018 | -8.738M |
| December 31, 2017 | -10.13M |
| September 30, 2017 | -12.97M |
| June 30, 2017 | -7.826M |
| March 31, 2017 | -5.965M |
| December 31, 2016 | -7.113M |
| September 30, 2016 | -14.96M |
| June 30, 2016 | -8.006M |
| March 31, 2016 | -9.42M |
| December 31, 2015 | -4.459M |
| September 30, 2015 | -3.702M |
| June 30, 2015 | -3.719M |
| March 31, 2015 | -5.045M |
| December 31, 2014 | -9.928M |
| September 30, 2014 | -3.13M |
| June 30, 2014 | -21.92M |
| March 31, 2014 | -4.797M |
| December 31, 2013 | -3.169M |
| September 30, 2013 | -5.078M |
| June 30, 2013 | -2.928M |
| March 31, 2013 | -7.123M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-508.58M
Minimum
Jun 2023
15.24M
Maximum
Mar 2024
-41.38M
Average
-8.916M
Median
Cash from Investing (Quarterly) Benchmarks
| Omeros Corp | 73.15M |
| Harrow Inc | 5.103M |
| PetIQ Inc | 0.982M |
| Amneal Pharmaceuticals Inc | -6.465M |
| Alector Inc | 37.15M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 69.11M |
| Cash from Financing (Quarterly) | -10.72M |
| Free Cash Flow | 178.13M |
| Free Cash Flow Per Share (Quarterly) | 1.212 |
| Free Cash Flow to Equity (Quarterly) | 70.40M |
| Free Cash Flow to Firm (Quarterly) | 67.05M |
| Free Cash Flow Yield | 7.00% |